U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

U.S. Physical Therapy, Inc. (USPH) is a Medical - Care Facilities company based in US with a market capitalization of $981M. Revenue grew 16.3% year-over-year and the company generated $61M in free cash flow. This page tracks USPH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4.03K employees · IPO May 29, 1992

Valuation

Valuation & price

$62.81 · as of May 17, 2026 · -32.6% vs 52w high

63.3

P/E ratio

Latest-FY diluted EPS

2.06

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$91.34$75.31$59.29Jul 25Dec 25Jul 26Jul 7, 25$79.36Jul 9, 25$76.48Jul 11, 25$74.50Jul 15, 25$73.16Jul 17, 25$74.95Jul 21, 25$74.94Jul 23, 25$75.53Jul 25, 25$74.25Jul 29, 25$75.64Jul 31, 25$73.15Aug 4, 25$70.36Aug 6, 25$72.69Aug 11, 25$86.71Aug 13, 25$88.52Aug 15, 25$85.78Aug 19, 25$84.75Aug 21, 25$84.47Aug 25, 25$85.47Aug 27, 25$84.61Aug 29, 25$82.89Sep 3, 25$83.75Sep 5, 25$85.64Sep 9, 25$84.36Sep 11, 25$82.01Sep 16, 25$78.44Sep 18, 25$80.15Sep 22, 25$79.87Sep 24, 25$81.89Sep 26, 25$83.40Sep 30, 25$84.95Oct 2, 25$87.20Oct 6, 25$89.53Oct 8, 25$90.38Oct 10, 25$87.72Oct 14, 25$90.97Oct 16, 25$89.50Oct 21, 25$89.62Oct 23, 25$91.34Oct 27, 25$91.00Oct 29, 25$88.08Oct 31, 25$86.27Nov 4, 25$87.04Nov 6, 25$77.56Nov 10, 25$73.30Nov 12, 25$72.53Nov 14, 25$71.67Nov 18, 25$68.94Nov 20, 25$68.41Nov 25, 25$74.16Nov 28, 25$73.85Dec 2, 25$73.47Dec 4, 25$76.30Dec 8, 25$75.34Dec 10, 25$79.28Dec 12, 25$80.59Dec 16, 25$78.50Dec 18, 25$78.72Dec 22, 25$80.45Dec 24, 25$80.24Dec 29, 25$81.42Jan 2, 26$78.88Jan 6, 26$81.25Jan 8, 26$81.48Jan 12, 26$84.29Jan 14, 26$85.92Jan 16, 26$86.00Jan 21, 26$86.01Jan 23, 26$85.70Jan 27, 26$83.03Jan 29, 26$82.36Feb 2, 26$83.66Feb 4, 26$82.60Feb 9, 26$84.48Feb 11, 26$88.14Feb 13, 26$86.94Feb 18, 26$86.44Feb 20, 26$85.09Feb 24, 26$82.88Feb 26, 26$79.34Mar 2, 26$83.03Mar 4, 26$84.09Mar 6, 26$81.09Mar 10, 26$79.99Mar 12, 26$77.88Mar 17, 26$77.41Mar 19, 26$74.33Mar 23, 26$75.20Mar 25, 26$74.96Mar 27, 26$74.75Mar 31, 26$74.96Apr 2, 26$73.74Apr 7, 26$74.86Apr 9, 26$77.01Apr 13, 26$78.34Apr 15, 26$76.67Apr 17, 26$76.57Apr 22, 26$75.52Apr 24, 26$73.53Apr 28, 26$72.54Apr 30, 26$71.22May 4, 26$70.92May 6, 26$73.65May 8, 26$59.29May 12, 26$60.85May 14, 26$65.09May 18, 26$65.04May 20, 26$62.24May 22, 26$61.96May 28, 26$63.89Jun 1, 26$62.53Jun 3, 26$61.87Jun 5, 26$63.45Jun 9, 26$61.80Jun 11, 26$65.79Jun 15, 26$65.52Jun 17, 26$62.84Jun 22, 26$62.51Jun 24, 26$66.21Jun 26, 26$68.78Jul 2, 26$71.76
$59.0052-week range$93.16
Loading valuation history…

Fundamentals

Key fundamentals

$981M

Market cap

16.3%

Revenue growth (YoY)

20.1%

Gross margin

$61M

Free cash flow (USD)

$390.2M

Net debt

0.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

FY 2016$356.5MFY 2017$414.1MFY 2018$453.9MFY 2019$482.0MFY 2020$423.0MFY 2021$495.0MFY 2022$553.1MFY 2023$604.8MFY 2024$671.3MFY 2025$781.0M
$356.5M$781M

Free cash flow by year

20162025

FY 2016$42.8MFY 2017$49.4MFY 2018$65.8MFY 2019$52.3MFY 2020$92.4MFY 2021$68.2MFY 2022$50.3MFY 2023$72.7MFY 2024$65.8MFY 2025$61.0M
$42.8M$61M

Gross margin by year

20212025

FY 202123.7%FY 202220.3%FY 202320.1%FY 202418.5%FY 202520.1%
23.7%20.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $49KMinan Peter Francis · Director · $48.8KJun 10, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 19, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • 8-K eventCredit Agreement AmendedApr 15, 2026Filing

Questions

Frequently asked questions

What is U.S. Physical Therapy, Inc.'s market cap?

U.S. Physical Therapy, Inc. (USPH) has a market capitalization of $981M.

What is USPH's P/E ratio?

USPH trades at a price-to-earnings ratio of 63.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is USPH's price-to-book (P/B) ratio?

USPH trades at 2.06 times book value per share.

Are insiders buying USPH stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at U.S. Physical Therapy, Inc. in the last 90 days.

Same arena

Related companies in Medical - Care Facilities

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.